Metabolic Conditions Identified by Tests Listed
PAAs . | P-HCY . | Acylcarn . | UOA . | UPP . | UGAA/Cr . | UMPS . | UOligo . |
---|---|---|---|---|---|---|---|
Argininosuccinic aciduriaa | Cobalamin C deficiency | Cobalamin C deficiency | β-ketothiolase deficiency | Pyrimidine 5′nucleotidase superactivity | AGAT deficiency | Hurler | α-mannosidosis |
Citrullinemiaa | Cobalamin D deficiency | Cobalamin D deficiency | Cobalamin A deficiency | Molybdenum cofactor type A deficiency | GAMT deficiency | Hunter | Aspartylglucosaminuria |
Citrullinemia, type IIa | Cobalamin F deficiency | Cobalamin F deficiency | Cobalamin B deficiency | Creatine transporter defect | Sanfilippo A, B, C | ||
CPS deficiencya | Cobalamin E deficiency | Ethylmalonic encephalopathy | Cobalamin C deficiency | Sly (MPS VI) | |||
Argininemiaa | Cobalamin G deficiency | Isovaleric acidemiaa | Cobalamin D deficiency | ||||
HHH syndrome | MTHFR deficiencya | 3-methylcrotonyl glycinuria | Cobalamin F deficiency | ||||
Maple syrup urine disease, variant | Homocystinuria | PPAa | Ethylmalonic encephalopathy | ||||
NAGS deficiencya | Tyrosinemia, type II | GA, type I | |||||
MTHFR deficiencya | GA, type II | ||||||
OTC deficiencya | HMG-CoA Lyase deficiency | ||||||
PKU | Holocarboxylase synthetase deficiency | ||||||
PDH complex deficiency | Homocystinuria | ||||||
Tyrosinemia, type II | Isovaleric acidemiaa | ||||||
3-methylcrotonyl glycinuria | |||||||
3-methylglutaconic aciduria | |||||||
MMAa | |||||||
MHBD deficiency | |||||||
PPAa | |||||||
SCOT deficiency | |||||||
SSADH deficiency | |||||||
Tyrosinemia, type II |
PAAs . | P-HCY . | Acylcarn . | UOA . | UPP . | UGAA/Cr . | UMPS . | UOligo . |
---|---|---|---|---|---|---|---|
Argininosuccinic aciduriaa | Cobalamin C deficiency | Cobalamin C deficiency | β-ketothiolase deficiency | Pyrimidine 5′nucleotidase superactivity | AGAT deficiency | Hurler | α-mannosidosis |
Citrullinemiaa | Cobalamin D deficiency | Cobalamin D deficiency | Cobalamin A deficiency | Molybdenum cofactor type A deficiency | GAMT deficiency | Hunter | Aspartylglucosaminuria |
Citrullinemia, type IIa | Cobalamin F deficiency | Cobalamin F deficiency | Cobalamin B deficiency | Creatine transporter defect | Sanfilippo A, B, C | ||
CPS deficiencya | Cobalamin E deficiency | Ethylmalonic encephalopathy | Cobalamin C deficiency | Sly (MPS VI) | |||
Argininemiaa | Cobalamin G deficiency | Isovaleric acidemiaa | Cobalamin D deficiency | ||||
HHH syndrome | MTHFR deficiencya | 3-methylcrotonyl glycinuria | Cobalamin F deficiency | ||||
Maple syrup urine disease, variant | Homocystinuria | PPAa | Ethylmalonic encephalopathy | ||||
NAGS deficiencya | Tyrosinemia, type II | GA, type I | |||||
MTHFR deficiencya | GA, type II | ||||||
OTC deficiencya | HMG-CoA Lyase deficiency | ||||||
PKU | Holocarboxylase synthetase deficiency | ||||||
PDH complex deficiency | Homocystinuria | ||||||
Tyrosinemia, type II | Isovaleric acidemiaa | ||||||
3-methylcrotonyl glycinuria | |||||||
3-methylglutaconic aciduria | |||||||
MMAa | |||||||
MHBD deficiency | |||||||
PPAa | |||||||
SCOT deficiency | |||||||
SSADH deficiency | |||||||
Tyrosinemia, type II |
Adapted from van Karnebeek and Stockler.41
Acylcarn, acylcarnitine profile; CPS, carbamyl phosphate synthetase; GA, glutaric acidemia; HHH, hyperornithinemia-hyperammonemia-homocitrullinuria; HMG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme A; MHBD, 2-methyl-3-hydroxybutyryl CoA dehydrogenase; MMA, methylmalonic acidemia; MTHFR, methylenetetrahydrofolate reductase; NAGS, N-acetylglutamate synthase; OTC, ornithine transcarbamylase; PAA, plasma amino acids; PDH, pyruvate dehydrogenase; P-HCY, plasma homocysteine; PKU; phenylketonuria; PPA, propionic acid; SCOT, succinyl-CoA:3-ketoacid CoA transferase; SSADH, succinic semialdehyde dehydrogenase; UGAA/creat; urine guanidino acid/creatine metabolites; UMPS, urine mucopolysaccharides qualitative screen (glycosaminoglycans); UOA, urine organic acids; UOGS, urine oligosaccharides; UPP, urine purines and pyrimidines.
Late-onset form of condition listed; some conditions are identified by more than 1 metabolic test.